134 related articles for article (PubMed ID: 7505083)
21. [Silver-stained Nucleolar Organizer Regions (AgNOR)].
Derenzini M; Trerè D
Pathologica; 2001 Apr; 93(2):99-105. PubMed ID: 11428299
[TBL] [Abstract][Full Text] [Related]
22. Morphometric analysis of AgNORs in the lymph node lesions.
Arora B; Jain R; Kumar S; Rekhi B; Arora H; Arora DR
Adv Clin Path; 2002 Apr; 6(2):95-9. PubMed ID: 19753731
[TBL] [Abstract][Full Text] [Related]
23. Location of nucleolar organizer regions (AgNORs) in the nuclei of astrocytic tumors.
Pedal WP; Warzok RW; Hufnagl P; Roth K
Clin Neuropathol; 1995; 14(1):55-61. PubMed ID: 7729083
[TBL] [Abstract][Full Text] [Related]
24. Nucleolar organizer regions (AgNORs) in in situ and invasive components of breast cancers.
Răşinaru A; Olinici CD; Blaga ML
Rom J Morphol Embryol; 1994; 40(1-2):7-10. PubMed ID: 7640380
[TBL] [Abstract][Full Text] [Related]
25. Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry.
Singh M; Prasad S; Kalra N; Singh U; Shukla Y
Oncology; 2006; 71(5-6):411-6. PubMed ID: 17785995
[TBL] [Abstract][Full Text] [Related]
26. [Significance of the AgNOR in tumor pathology].
Pich A; Margaria E; Chiusa L
Pathologica; 2002 Feb; 94(1):2-9. PubMed ID: 11912874
[TBL] [Abstract][Full Text] [Related]
27. Nucleolus organizer regions (AgNORs) in ductal mammary carcinoma. Comparison with classifications and prognosis.
Aubele M; Auer G; Gais P; Jütting U; Rodenacker K; Voss A
Pathol Res Pract; 1994 Feb; 190(2):129-37. PubMed ID: 7520163
[TBL] [Abstract][Full Text] [Related]
28. The relation of argyrophilic proteins of nucleolar organizer regions (AgNORs) to the proportions of Ki-67 or DNA polymerase alpha-reacting cells in non-Hodgkin's lymphomas.
Okabe Y; Nakamura S; Okumura H; Matano S; Kobayashi K; Ohtake S; Yoshida T; Matsuda T; Mizukami Y; Nonomura A
Anticancer Res; 1991; 11(6):2031-5. PubMed ID: 1723261
[TBL] [Abstract][Full Text] [Related]
29. Quantitative analysis of three-dimensional distribution of AgNOR proteins during interphase in leukemic cells.
Wozniak ZM; Usson Y; Parazza F; Champelovier P; Leroux D; Seigneurin D
Cytometry; 1996 May; 24(1):14-26. PubMed ID: 8723898
[TBL] [Abstract][Full Text] [Related]
30. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
[TBL] [Abstract][Full Text] [Related]
31. Combined light and fluorescent microscopical imaging of nucleolar organizer regions and cellular rRNA as detected by fluorescent in situ hybridization.
Pajor L; Honeyman TW
Cytometry; 1995 Feb; 19(2):171-6. PubMed ID: 7743896
[TBL] [Abstract][Full Text] [Related]
32. Interphase AgNOR quantity and DNA content in endometrial adenocarcinoma.
Trerè D; Melchiorri C; Chieco P; Marabini A; Derenzini M
Gynecol Oncol; 1994 May; 53(2):202-7. PubMed ID: 8188080
[TBL] [Abstract][Full Text] [Related]
33. Morphometric determination of AgNORs in breast carcinoma. Correlation with flow cytometry and proliferating cell nuclear antigen.
Bellotti M; Elsner B; Kahn A; Bezodnick L; Pisilli L; Greco P
Anal Quant Cytol Histol; 1997 Apr; 19(2):139-44. PubMed ID: 9113306
[TBL] [Abstract][Full Text] [Related]
34. [Measurement of nucleolar organizers (AgNOR) using the LUCIA-M color image analysis system].
Dusková J; Povýsil C
Cesk Patol; 1995 Feb; 31(1):17-20. PubMed ID: 8599845
[TBL] [Abstract][Full Text] [Related]
35. Demonstration of the nucleolar organizer region by silver staining (AgNOR method) in research and in histopathological practice.
Kodousek R; Dusek J
Acta Univ Palacki Olomuc Fac Med; 1991; 131():9-37. PubMed ID: 1726500
[TBL] [Abstract][Full Text] [Related]
36. Standardized demonstration of silver-stained nucleolar organizer regions-associated proteins in archival oral squamous cell carcinomas and adjacent non-neoplastic mucosa.
Piffkò J; Bànkfalvi A; Ofner D; Rasch D; Joos U; Schmid KW
Mod Pathol; 1997 Feb; 10(2):98-104. PubMed ID: 9127314
[TBL] [Abstract][Full Text] [Related]
37. AgNOR quantification with special reference to staining patterns.
Rüschoff J; Fauser G; Knüchel R; Hofstädter F
Zentralbl Pathol; 1994 Mar; 140(1):23-30. PubMed ID: 7515669
[TBL] [Abstract][Full Text] [Related]
38. Silver-binding nucleolar organizer regions (AgNORs) in the normal epithelium of different parts of the digestive tract in rats.
Zaczek M; Maciejowski J; Gil K; Szot W; Chłap Z
Folia Histochem Cytobiol; 1994; 32(2):127-35. PubMed ID: 7958071
[TBL] [Abstract][Full Text] [Related]
39. Computer-assisted and visual methods of assessing cellular proliferation in tissue sections from non-Hodgkin's lymphoma a comparison.
Hendricks JB; Rainer R; Munakata S
Anal Quant Cytol Histol; 1995 Dec; 17(6):383-8. PubMed ID: 8750352
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of AgNOR count in distinguishing benign from malignant mesothelial cells in pleural fluids.
Colecchia M; Leopardi O
Pathol Res Pract; 1992 Jun; 188(4-5):541-4. PubMed ID: 1409085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
